Lioton

Heparin Sodium, the active ingredient in Lioton, is an anticoagulant presented as a topical formulation for external use. It is employed to manage superficial clotting disorders and related skin conditions. GNH USA supplies Lioton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lioton is a topical anticoagulant that acts on superficial vascular and skin conditions. - Superficial thrombophlebitis: helps reduce clot formation and inflammation in superficial veins. - Bruising (contusions): facilitates resolution of hematoma and limits swelling. - Varicose vein discomfort: alleviates local pain and edema associated with varicose veins.

Topical application of Lioton may be associated with local and systemic adverse reactions.

Common Side Effects: - Skin irritation: redness or mild discomfort at the application site. - Erythema: localized redness. - Itching: mild pruritus. - Burning sensation: transient warmth. - Dryness: mild skin dryness.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or anaphylaxis. - Severe skin necrosis: localized tissue death. - Systemic anticoagulation: unexpected bleeding. - Heparin‑induced thrombocytopenia (HIT): drop in platelet count. - Extensive bruising: disproportionate bleeding under skin.

When using Lioton, consider the following safety measures. - Pregnancy: safety not established; avoid use unless clearly needed. - Bleeding disorders: contraindicated in patients with active bleeding. - Open wounds: do not apply to broken skin or large abrasions. - Concurrent anticoagulants: monitor for additive bleeding risk. - Known heparin allergy: avoid use to prevent hypersensitivity. - Store at ambient temperature: keep in original packaging, protect from moisture and direct heat.

Lioton may interact with other agents that affect coagulation.

Major Interactions (Avoid): - Systemic anticoagulants (e.g., warfarin, direct oral anticoagulants): risk of excessive bleeding. - Thrombolytic agents (e.g., alteplase): increased hemorrhagic potential.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen, naproxen): may augment bleeding tendency. - Antiplatelet drugs (e.g., aspirin, clopidogrel): monitor for bruising. - Topical corticosteroids: may alter skin absorption of heparin.